Change - Announcement of Cessation::Announcement of Cessation of Chief Financial Officer
Issuer & Securities
STAR PHARMACEUTICAL LIMITED
STAR PHARMACEUTICAL LIMITED - SG1S90928817 - X64
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Announcement of Cessation of Chief Financial Officer
Submitted By (Co./ Ind. Name)
Xu Zhi Bin
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached.
Name Of Person
Chung Yim Ling
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
To pursue other career opportunities.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer.
Role and responsibilities
Responsible for overseeing the Group's accounting and financial matters.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Past (for the last 5 years)